CCND2 and neoplasm: Additionally, CCND2A (cyclin D2, key regulator of cell growth and replication) amplifications are highly prevalent in G34-mutant tumor tissue, especially those with primitive neuronal/neuroectodermal-like histology; questioning the efficacy of long-term cyclin-dependent kinase (CDK) inhibitor usage.